–
Olema Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.5
FY22:
−107
FY23:
−105
FY24:
−142
FY25:
−179
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.3
FY22:
−107
FY23:
−105
FY24:
−142
FY25:
−178
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.1
FY22:
−105
FY23:
−96.7
FY24:
−129
FY25:
−162
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.1
FY22:
−105
FY23:
−96.7
FY24:
−129
FY25:
−162
All amounts in millions USD